
    
      Patients with chronic hepatitis B infection and relevant liver fibrosis will be treated with
      entecavir during 5 years or until anti-HBs seroconversion or 6-12 months after anti-HBe
      seroconversion and HBeAg loss. There are 9 visits during treatment for each patient. At all
      visits, each patient will consent to give 20 ml blood sample for study examination and 40 ml
      blood sample for research purposes.
    
  